Increasing the precision of gene editing in vitro, ex vivo, and in vivo

被引:8
|
作者
Mueller, Katherine [1 ,2 ]
Carlson-Stevermer, Jared [1 ,2 ]
Saha, Krishanu [1 ,2 ]
机构
[1] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA
[2] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53715 USA
基金
美国国家科学基金会;
关键词
Genome editing; Gene therapy; Cell therapy; CRISPR-Cas9; Precision medicine; Regenerative Medicine;
D O I
10.1016/j.cobme.2018.08.006
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
New gene editing tools like CRISPR-Cas9 enable precision genome engineering within cell lines, primary cells, and model organisms, with some formulations now entering the clinic. "Precision" applies to various aspects of gene editing, and can be tailored for each application. Here we review recent advances in four types of precision in gene editing: 1) increased DNA cutting precision (e.g., on-target:off-target nuclease specificity), 2) increased on-target knock-in of sequence variants and transgenes (e.g., increased homology-directed repair), 3) increased transcriptional control of edited genes, and 4) increased specificity in delivery to a specific cell or tissue. Design of next-generation gene and cell therapies will likely exploit a combination of these advances.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 50 条
  • [1] Excision of HIV-1 DNA by gene editing: in vitro, ex vivo and in vivo studies
    Kaminski, R.
    Hu, W.
    Karn, J.
    Khalili, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [2] Gene editing for ex vivo pachyonychia congenita correction
    Diez, M. Garcia
    Sot, B.
    Moreno, M.
    Morin, M.
    Soletto, L.
    Fernandez, S.
    Prado, D.
    Murillas, R.
    Mencia, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S149 - S149
  • [3] Innovative nanoparticles for ex vivo and in vivo genome editing
    Pilet, H.
    Gerard, J.
    Jang, H.
    Kim, H. H.
    Grandchamp, N.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A104 - A104
  • [4] In vitro, ex vivo, in vivo veritas
    Borgström, L
    ALLERGY, 1999, 54 : 88 - 92
  • [5] EX VIVO IN VITRO
    Le Roux, Monique
    QUINZAINE LITTERAIRE, 2011, (1050): : 27 - 27
  • [6] Molecular Evidence of Ex Vivo Gene Editing in a Mouse Model of Immunodeficiency
    Abdul-Razak, Hayder H.
    Rocca, Celine
    Howe, Steve J.
    Alonso-Ferrero, Maria Eugenia
    Wang, Jianbin
    Gabriel, Richard
    Bartholomae, Cynthia
    Gan, C. H. Victor
    Garin, Marina I.
    Roberts, Alison
    Blundell, Michael P.
    Prakash, Versha
    Molina-Estevez, Francisco Javier
    Pantoglou, Julia
    Gueenechea, Guillermo
    Holmes, Michael C.
    Gregory, Philip D.
    Kinnon, Christine
    von Kalle, Christof
    Schmidt, Manfred
    Bueren, Juan A.
    Thrasher, Adrian J.
    Yanez-Munoz, Rafael J.
    MOLECULAR THERAPY, 2017, 25 (05) : 303 - 303
  • [7] DEVELOPMENT OF A PRECISION HEPATOCELLULAR CARCINOMA MODEL IN TRANSGENIC PIGS BY EX VIVO CRISPR EDITING
    Elkhadragy, Lobna
    Carlino, Maximillian J.
    Jordan, Luke R.
    Schook, Lawrence B.
    Gaba, Ron C.
    Schachtschneider, Kyle M.
    HEPATOLOGY, 2021, 74 : 684A - 684A
  • [8] Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo Prospects
    George, Christy A.
    Sahu, Srishti U.
    de Onate, Lorena
    Souza, Bruno Solano de Freitas
    Wilson, Ross C.
    CRISPR JOURNAL, 2024, 7 (05): : 231 - 248
  • [9] In vivo gene editing for gene therapy
    Jordan, Bertrand
    M S-MEDECINE SCIENCES, 2021, 37 (10): : 933 - 935
  • [10] Assays of CFTR Function In Vitro, Ex Vivo and In Vivo
    Ramalho, Anabela S.
    Boon, Mieke
    Proesmans, Marijke
    Vermeulen, Francois
    Carlon, Marianne S.
    De Boeck, Kris
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)